High-cost drug claims lead to 20-times greater cost per claim for small plan sponsors
A recent survey by Innovative Medicines Canada found there are growing listing delays among Canada’s private drug plans, said Joe Farago, the organization’s executive director of private payers and investment, during a session at Benefits Canada’s 2023 Face to Face Drug Plan Management Forum in December. The survey noted private payer review times can take […]
- January 22, 2024 January 18, 2024
- 08:00